By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Xenetic Biosciences  

Greener House
66-68 Haymarket
  London  SW1Y 4RF  United Kingdom
Phone: 44-0-20-3021-1500 Fax: 44-0-20-3021-1511


Company News
Xenetic Biosciences Reports Positive Topline Data From Third Cohort Of Phase 2 Dose-Escalation Trial Of Erepoxen For Anemia 10/10/2016 11:40:56 AM
Xenetic Biosciences To Present At The Ladenburg Thalmann 2016 Healthcare Conference 9/22/2016 11:10:45 AM
Xenetic Biosciences Announces FDA Acceptance Of Investigational New Drug Application To Initiate Phase II Clinical Trial Of Virexxa In Endometrial Cancer 8/19/2016 11:04:49 AM
Xenetic Biosciences Announces Collaboration With Excivion, UK, To Develop A Novel Combined Zika and Dengue Vaccine 8/18/2016 9:15:40 AM
Xenetic Biosciences Appoints Jeffrey F. Eisenberg To The Board Of Directors 7/11/2016 8:40:57 AM
Xenetic Biosciences Announces Reverse Stock Split In Preparation For Proposed Uplisting To Nasdaq Capital Market 6/1/2016 12:05:04 PM
Opko Health (OPK) Acquires Interest In Xenetic Biosciences 2/12/2016 10:01:29 AM
Xenetic Biosciences Enters Into Asset Purchase Agreement With Financing Component For The Rights To Develop, Market And License Oncologic Drug Candidate Virexxaâ„¢ 11/16/2015 11:15:26 AM
Xenetic Biosciences's Major Strategic Shareholders Enter Into Long Term Lock-Up Agreements 10/7/2015 11:16:11 AM
Xenetic Biosciences Launches Digital Corporate Communication Channels 9/2/2015 7:52:13 AM